This suggests that IL-5 may synergize with other cytokines such as IL-4 and IL-13 that are known to have a fibrotic by stimulating airway fibroblasts, further exacerbating airway remodelling [46], positioning it as a potential therapeutic target for fibrosis-related complications in asthma. Here, IL4 is linked to asthma.